CAMBRIDGE, Mass.--(BUSINESS WIRE)--Seventh Sense Biosystems, Inc., an early stage, venture-backed company developing a new generation of health diagnostics products, announced today that its Touch Activated Phlebotomy™ (TAP) technology has received the Gold Medal Award from The Edison Awards™ in the Science and Medicine – Diagnostic Aids Segment. These annual awards recognize innovation, creativity and ingenuity.
“We are extremely honored to be recognized by The Edison Awards for innovative achievement in healthcare diagnostics,” said Doug Levinson, Ph.D., chief executive officer and co-founder of Seventh Sense Biosystems and partner at Flagship Ventures. “We’ve made excellent progress in the development of our TAP technology, which enables simple, painless blood acquisition in a single step. These features address fundamental needs across the diagnostics and health monitoring markets. While still in the developmental stage, we expect to be able to announce important developments with our TAP technology in the not-too-distant future.”
About Touch Activated Phlebotomy™
Seventh Sense’s single-step Touch Activated Phlebotomy (TAP) technology is being developed to eliminate the discomfort, inconvenience, and expert intervention associated with traditional blood sample collection. TAP is designed to penetrate the uppermost layers of skin and uses a proprietary microfluidic extraction process to transfer blood to a collection reservoir for analysis. TAP’s unique and intuitive design is intended to be appropriate for use by anyone, anywhere, anytime. Importantly, TAP’s universal design can be integrated into a broad range of products across a spectrum of diagnostic applications.
About The Edison Awards™
The Edison Awards symbolize the persistence and excellence personified by Thomas Alva Edison, inspiring America’s drive to remain in the forefront of innovation, creativity and ingenuity in the global economy. Established in 1987 by the American Marketing Association, but an independent organization since 2008, the Edison Best New Product Awards™ have honored some of the most innovative products and business leaders in America.
The ballot of nominees for the Edison Best New Product Awards was judged by more than 2,000 members of the not-for-profit Marketing Executives Networking Group (MENG), an organization comprising America’s top marketing professionals and academics. In a comprehensive peer-review process, the nominees were judged on Marketplace Innovation, Marketplace Success, Technological Innovation, Market Structure Innovation, Societal Impact and Design Innovation.
About Seventh Sense Biosystems, Inc.
Seventh Sense Biosystems is an early stage, private company developing a new generation of blood access and diagnostic products that promise unprecedented convenience and simplicity of use. The company’s cornerstone technology, Touch Activated Phlebotomy™ is being used to develop safe and painless blood sampling and diagnostic products. Founded in 2008, Seventh Sense Biosystems is backed by top-tier investors including Flagship Ventures, Polaris Venture Partners and Third Rock Ventures. For more information, please visit www.7sbio.com. Contacts
Pure Communications, Inc. Sheryl Seapy, 949-608-0841
